Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vector

Cancer Research

Volumn 61, Issue 14, 2001, Pages 5336-5339

  Ichikawa, T ^a   Chiocca, E A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA VECTOR; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; TUMOR; TUMOR CELL; VIRUS REPLICATION;

ANIMALS; DEFECTIVE VIRUSES; GENE EXPRESSION; GENETIC VECTORS; HUMANS; LAC OPERON; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; SIMPLEXVIRUS; TIME FACTORS; TRANSFECTION; TRANSGENES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 0035878847     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. The development of conditionally replicative adenoviruses for cancer therapy
2. Oncolytic viruses as novel anticancer agents: Turning one scourge against another
3. Conditionally replicating herpes vectors for cancer therapy
4. Gene therapy of malignant brain tumors: A rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells
5. Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer
6. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene
7. Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses
8. Migration of genetically labeled glioma cells after implantation into murine brain
9. Transgene inheritance and retroviral infection contribute to the efficiency of gene expression in solid tumors inoculated with retroviral vector producer cells
10. Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells
11. From the cover: Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas
12. Separation of primary structural components conferring autoregulation, transactivation, and DNA-binding properties to the herpes simplex virus transcriptional regulatory protein ICP4
13. An ICP6: lacZ insertional mutagen is used to demonstrate that the UL52 gene of herpes simplex virus type 1 is required for virus growth and DNA synthesis
14. Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides
15. Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants
16. B-myb promoter retargeting of herpes simplex virus γ34.5 gene-mediated virulence toward tumor and cycling cells
17. A Phase I study of Onyx-015, an EIB attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer
18. A controlled trial of intratumoral ONYX-015. A selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
19. Conditionally replicating herpes simplex virus mutant, G207, for the treatment of malignant glioma: Results of a Phase I trial
20. Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: A new paradigm for destruction of therapeutically intractable tumors
21. Cytotoxicity, apoptosis, and viral replication in tumor cells treated with oncolytic ribonucleotide reductase-defective herpes simplex type 1 virus (hrR3) combined with ionizing radiation
22. Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies